Etiology and Pathogenesis > Caspases | Treatment > SI-27


Journal of Neuro-Oncology 66: 91–99, January 2004. (Laboratory Investigation)


Abstract

Drug-induced apoptosis by a matrix metalloproteinase inhibitor, SI-27 on human malignant glioma cell lines; in vitro study

Ryuzaburo Kanazawa, Daizo Yoshida, Hiroshi Takahashi, Yuichi Sugisaki, Satoru Suzuki and Akira Teramoto

Department of Neurosurgery (R.K., D.Y., H.T., A.T.), Central Institute for Electron Microscopic Researches (Y.S.), Department of Biochemistry and Molecular Biology (S.S.), Nippon Medical School, Tokyo, Japan

Matrix metalloproteinase (MMP) plays important roles in cell invasion and tumor angiogenesis. 
SI-27, an anti-MMP agent, has already been shown to possess both in vitro anti-invasive and anti-angiogenic properties against malignant gliomas in non-cytotoxic dose concentrations. 
However, to the best of our knowledge, the molecular mechanism mediating the cytotoxic action by this agent and the molecular mechanism in the cytotoxic action against malignant glioma cell have not yet been clarified. 
Therefore, we assessed the effect in the cytotoxic dose concentrations to investigate whether this cytotoxic action is related to apoptosis in this study. 
The effect on human glioma cell lines (U87MG, U251MG, and U373MG) was examined by transmission electron microscope, agarose gel electrophoresis with the DNA fragmentation, flow cytometry with FITC-conjugated Annexin V, and detection of caspase activity. 
Drug-induced apoptosis was observed in the cytotoxic dose. 
The result indicated that the cytotoxity of SI-27 might be related to the drug-induced apoptosis mediated by caspase. 

Key words: apoptosis, caspase, malignant glioma, matrix metalloproteinase, SI-27

© 2004 Kluwer Academic Publishers. Printed in the Netherlands.

Source: http://journals.kluweronline.com/article.asp?PIPS=5146807


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP